Laboratorios Farmaceuticos ROVI SA
MAD:ROVI
Wall Street
Price Targets
ROVI Price Targets Summary
Laboratorios Farmaceuticos ROVI SA
According to Wall Street analysts, the average 1-year price target for
ROVI
is 76.1 EUR
with a low forecast of 66.66 EUR and a high forecast of 97.65 EUR.
Operating Income
Forecast
Operating Income Estimate
Laboratorios Farmaceuticos ROVI SA
For the last 8 years the
compound annual growth rate for
Laboratorios Farmaceuticos ROVI SA's operating income is
33%.
The projected
CAGR
for the next 3 years is
14%.
Net Income
Forecast
Net Income Estimate
Laboratorios Farmaceuticos ROVI SA
For the last 8 years the
compound annual growth rate for
Laboratorios Farmaceuticos ROVI SA's net income is
31%.
The projected
CAGR
for the next 3 years is
17%.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is ROVI's stock price target?
Price Target
76.1
EUR
According to Wall Street analysts, the average 1-year price target for
ROVI
is 76.1 EUR
with a low forecast of 66.66 EUR and a high forecast of 97.65 EUR.
What is Laboratorios Farmaceuticos ROVI SA's Revenue forecast?
Projected CAGR
8%
For the last 8 years the
compound annual growth rate for
Laboratorios Farmaceuticos ROVI SA's revenue is
16%.
The projected
CAGR
for the next 3 years is
8%.
What is Laboratorios Farmaceuticos ROVI SA's Operating Income forecast?
Projected CAGR
14%
For the last 8 years the
compound annual growth rate for
Laboratorios Farmaceuticos ROVI SA's operating income is
33%.
The projected
CAGR
for the next 3 years is
14%.
What is Laboratorios Farmaceuticos ROVI SA's Net Income forecast?
Projected CAGR
17%
For the last 8 years the
compound annual growth rate for
Laboratorios Farmaceuticos ROVI SA's net income is
31%.
The projected
CAGR
for the next 3 years is
17%.
You don't have any saved screeners yet
